ArticleAnnals of vascular diseases2012
Late-onset primary intestinal lymphangiectasia successfully managed with octreotide: a case report.
Article in Annals of vascular diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 24 citations in OpenAlex.
- First case report of intestinal lymphangiectasia with refractory bleeding from the duodenum, successfully treated by intra-abdominal lymphaticovenous anastomosis with venous ligation.Clinical journal of gastroenterology · 2024Article
- Hypocalcaemic tetany linked to vitamin D deficiency and hypomagnesemia in primary intestinal lymphangiectasia: a literature review.Annals of medicine and surgery (2012) · 2024Review
- Experience of primary intestinal lymphangiectasia in adults: Twelve case series from a tertiary referral hospital.World journal of clinical cases · 2024Article
- Pathophysiology, Diagnosis, and Management of Canine Intestinal Lymphangiectasia: A Comparative Review.Animals : an open access journal from MDPI · 2022Review
- The Update of Treatment for Primary Intestinal Lymphangiectasia.Pediatric gastroenterology, hepatology & nutrition · 2021Review
- Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature.BMC pediatrics · 2021Review
- Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.World journal of gastroenterology · 2020Review
- Article
- Primary intestinal lymphangiectasia in an elderly female patient: A case report on a rare cause of secondary immunodeficiency.Medicine · 2017Article
- Intestinal Lymphangiectasia: Insights on Management and Literature Review.The American journal of case reports · 2016Review
- How to treat an extensive form of primary intestinal lymphangiectasia?World journal of gastroenterology · 2015Article
- Use of octreotide for the treatment of protein-losing enteropathy in dogs: Retrospective study of 18 cases.Journal of veterinary internal medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a patient with late-onset primary lymphangiectasia whose persistent diarrhoea was successfully managed with octreotide. A 63 year-old man visited our clinic with a complaint of worsening general edema. Gastrointestinal endoscopy revealed typical whitish jejunal villi, which suggested primary intestinal lymphangiectasia. Despite a diet, supplemented with medium-chain triglycerides; antiplasmin therapy; oral corticosteroids; and surgery, including pericardial window and lymphaticovenous anastomoses; his symptoms, including watery diarrhoea, showed no improvement. After administration of octreotide, his persistent diarrhoea resolved within a couple of days. Octreotide was continued for 2 months. Thereafter, his diarrhoea has not recurred for 6 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.